Generation of a polyclonal antibody against lipid peroxide-modified proteins

被引:45
作者
Kim, JG
Sabbagh, F
Santanam, N
Wilcox, JN
Medford, RM
Parthasarathy, S
机构
[1] EMORY UNIV,SCH MED,DEPT GYNECOL & OBSTET,ATLANTA,GA 30322
[2] EMORY UNIV,DEPT MED,ATLANTA,GA 30322
关键词
atherosclerosis; lipid peroxidation; aldehydes; low-density lipoprotein; oxidized low-density lipoprotein;
D O I
10.1016/S0891-5849(96)00615-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A specific polyclonal antibody against the lipid peroxide (LOOH)-modified rabbit serum albumin(RSA) was generated in rabbits. The antibody selectively recognized the modified protein in a concentration-dependent manner and did not cross react with aldehyde-modified proteins or proteins directly oxidized with the free radical generator 2,2'-azobis (2-amidinopropane) hydrochloride (AAPH). Oxidized low-density lipoprotein (Ox-LDL), but not native LDL, was also recognized by the antibody in a concentration-dependent manner. The antibody also cross reacted with several other proteins modified by LOOH suggesting that the antibody is directed towards a common epitope and not towards the protein sequence. Western blot analysis of normal human plasma showed that at least three different proteins are recognized by the antibody. RAW cells, preincubated with LOOH, were immunostained with the antibody and the antigenic epitopes were present intracellularly, while controls lacking in the primary antibodies failed to show immunoreactivity. Atherosclerotic arteries from cholesterol-fed monkeys and human atherosclerotic lesions were also immunostained by the antibody. The immunoreactivity was co-localized in areas rich in foam cell macrophages. These results suggest that LOOH-modified proteins present an unique antigenic epitope that may represent a primary product of interaction of LOOH with proteins. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:251 / 259
页数:9
相关论文
共 29 条
[1]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[2]   PROTEIN MODIFICATION BY OXIDANTS AND THE ROLE OF PROTEOLYTIC-ENZYMES [J].
DAVIES, KJA .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1993, 21 (02) :346-353
[3]  
ESTERBAUER H, 1987, J LIPID RES, V28, P495
[4]   FLUORESCENT MODIFICATION OF SERUM ALBUMIN BY LIPID PEROXIDATION [J].
FLETCHER, BL ;
TAPPEL, AL .
LIPIDS, 1971, 6 (03) :172-+
[5]  
FONG LG, 1987, J LIPID RES, V28, P1466
[6]   Task force 4. Efficacy of risk factor management [J].
Forrester, JS ;
Merz, CNB ;
Bush, TL ;
Cohn, JN ;
Hunninghake, DB ;
Parthasarathy, S ;
Superko, HR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (05) :991-1006
[7]   EVIDENCE FOR A CONCERTED REACTION BETWEEN LIPID HYDROPEROXIDES AND POLYPEPTIDES [J].
FRUEBIS, J ;
PARTHASARATHY, S ;
STEINBERG, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) :10588-10592
[8]   MALONDIALDEHYDE-ALTERED PROTEIN OCCURS IN ATHEROMA OF WATANABE HERITABLE HYPERLIPIDEMIC RABBITS [J].
HABERLAND, ME ;
FONG, D ;
CHENG, L .
SCIENCE, 1988, 241 (4862) :215-218
[9]   TYROSYL RADICAL GENERATED BY MYELOPEROXIDASE CATALYZES THE OXIDATIVE CROSS-LINKING OF PROTEINS [J].
HEINECKE, JW ;
LI, W ;
FRANCIS, GA ;
GOLDSTEIN, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2866-2872
[10]   MALONDIALDEHYDE AND 4-HYDROXYNONENAL PROTEIN ADDUCTS IN PLASMA AND LIVER OF RATS WITH IRON OVERLOAD [J].
HOUGLUM, K ;
FILIP, M ;
WITZTUM, JL ;
CHOJKIER, M .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (06) :1991-1998